SomaLogic, Inc. (NASDAQ:SLGCW) Short Interest Down 19.7% in January
SomaLogic, Inc. (NASDAQ:SLGCW) Short Interest Down 19.7% in January
SomaLogic, Inc operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples.SomaLogic, Inc. (NASDAQ:SLGCW – Get Rating) was the recipient of a significant drop in short interest in January. As of January 31st, there was short interest totalling 20,800 shares, a drop of 19.7% from the January 15th total of 25,900 shares. Based on an average daily volume of 11,300 shares, the days-to-cover ratio is presently 1.8 days.
索馬洛奇, 公司. (NASDAQ: SLGCW — 獲取評級) 是一月份短期利益顯著下降的收件人.截至 1 月 31 日，短期利息總額為 20,800 股，較 1 月 15 日的總額 25,900 股股份下降 19.7%。根據每日平均成交量為 11,300 股，日數佔覆蓋率目前為 1.8 天。
Institutional Trading of SomaLogic
索馬洛奇的機構交易
A number of hedge funds have recently made changes to their positions in the business. Saba Capital Management L.P. acquired a new stake in shares of SomaLogic in the third quarter valued at approximately $43,000. LMR Partners LLP lifted its position in shares of SomaLogic by 64.0% in the third quarter. LMR Partners LLP now owns 573,577 shares of the company's stock valued at $1,663,000 after buying an additional 223,842 shares during the last quarter. Finally, Point72 Asset Management L.P. lifted its position in shares of SomaLogic by 4.1% in the third quarter. Point72 Asset Management L.P. now owns 1,267,427 shares of the company's stock valued at $556,000 after buying an additional 50,000 shares during the last quarter.
一些對沖基金最近更改了他們在業務中的頭寸。薩巴資本管理有限責任公司在第三季度收購了索馬洛吉股份的新股份，價值約為 4.3 萬美元。LMR 合作夥伴有限責任公司在第三季度提升了 64.0% 在索馬洛吉股份的地位。LMR 合夥人有限責任公司在上一季度額外購買 223,842 股股票後，現在擁有該公司股票的 573,577 股價值 1,663,000 美元。最後，Point72 資產管理有限責任公司在第三季度將其在索馬洛吉股份的頭寸上調了 4.1%。七十二點資產管理有限責任公司在上一季度額外購買 50,000 股股份後，擁有該公司股票價值 556,000 美元的 1,267,427 股。
SomaLogic Stock Down 5.4 %
索馬洛基股票下跌 5.4%
SLGCW stock opened at $0.44 on Monday. The company has a 50 day moving average of $0.47. SomaLogic has a twelve month low of $0.27 and a twelve month high of $3.44.
SLG 證券周一以 0.44 美元開盤。該公司擁有 50 天移動平均線 0.47 美元。索馬洛能有十二個月低點 0.27 美元，十二個月高點為 3.44 美元。
SomaLogic Company Profile
索马洛奇公司简介
SomaLogic, Inc operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples.
Somalogic 公司在美國是一家蛋白質生物標誌物發現和臨床診斷公司。它開發了緩慢的偏離率改性適當劑（SoMmers），這是改性的核酸蛋白質結合試劑，特定於其干擾蛋白；並提供專有的 SomasCAN 服務，提供多重蛋白檢測和定量複雜生物樣本中蛋白質水平的多重蛋白質水平。
Read More
閱讀更多
- Get a free copy of the StockNews.com research report on SomaLogic (SLGCW)
- MarketBeat Week in Review – 2/6 – 2/10
- Will Snowflake Have Tough Sledding, Trying To Keep Rally Alive?
- The Bottom Is In For Cloudflare Stock
- 3 Tickers Leading a Meme Stock Revival
- Microsoft-Activision Blizzard Merger: Navigating Risk and Reward
- 獲取有關索馬洛奇（SLGCW）的研究報告的免費副本
- 市場節拍週的回顧 — 2/6 — 2/10
- 雪花會有艱難的雪橇，試圖保持拉力賽活著嗎？
- 底部是雲耀斑股票
- 3 個帶領模因股票復興的行情
- 微軟動視暴雪合併：導航風險與回報
Receive News & Ratings for SomaLogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SomaLogic and related companies with MarketBeat.com's FREE daily email newsletter.
接收索馬洛吉日報的新聞和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊接收 Somalogic 及相關公司的最新新聞和分析師評級的簡要每日摘要。
